Phase II studies of BEZ235 in patients with advanced pancreatic neuroendocrine tumors (pNET).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ramon Salazar, Chris Verslype, Eric Baudin, Steven K. Libutti, James C. Yao, Roberto Buzzoni, Lorenzo Antonuzzo, Richard Hubner, Rocio García-Carbonero, Ana B. Custodio, Edward M. Wolin, Sabine Turri, Debarshi Dey, Paola Aimone, Joseph Sulovski, Nabanita Mukherjee, Fabian Herbst, Nicola Fazio
Institutions: Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Universitair Ziekenhuis Leuven, Institut Gustave Roussy, Albert Einstein College of Medicine, The University of Texas MD Anderson Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliero-Universitaria Careggi, The Christie Hospital, Hospital Universitario Virgen del Rocío, Hospital Universitario La Paz, University of Kentucky, Novartis (France), Novartis (India), Novartis (Switzerland), European Institute of Oncology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2214586747